David Wallington, MD
Clinical Assistant Professor, Department of Medicine
Biosketch
David Wallington, MD, is a radiation oncologist at Bronson Battle Creek Hospital. He received his undergraduate degree at the University of Michigan, where he also completed a masters degree in human physiology. He completed medical school at Western Michigan University Homer Stryker MD School of Medicine in 2020. He completed a transitional year residency at Riverside Regional Medical Center in Newport News, VA, before going on to complete his residency in radiation oncology at Yale including a chief resident year. His clinical interests include breast, prostate, and lung cancer, as well as low dose radiation therapy (LDRT) for benign conditions such as osteoarthritis.
-
- Residency 2025, Radiation Oncology, Yale New Haven Hospital
- Residency 2021, Riverside Regional Medical Center
- MD 2020, Western Michigan University Homer Stryker M.D. School of Medicine
- MS 2014, Physiology, Rackham Graduate School, University of Michigan
- BS 2013, Kinesiology, University of Michigan
-
- oligometastatic cancer
- Prostate Cancer
- Lung Cancer
- Head and Neck Cancers
- Breast Cancer
- Arthritis treatments
-
Wallington D.G., Imber B.S., Scordo M., Robinson T.J. The Role of Radiotherapy in Lymphoma Patients Undergoing CAR T Therapy: Past, Present, and Future Seminars in Radiation Oncology. 2025;35(1):99-109.
Maroongroge S., Pinnix C.C., Wallington D.G., Taylor P.A., Zhu D., Guadagnolo B.A., Smith B.D., Yu J.B., Ballas L.K. In Reply to Smith et al. International Journal of Radiation Oncology Biology Physics. 2022;113(3):696-697.
Maroongroge S., Wallington D.G., Taylor P.A., Zhu D., Guadagnolo B.A., Smith B.D., Yu J.B., Ballas L.K. Geographic Access to Radiation Therapy Facilities in the United States International Journal of Radiation Oncology Biology Physics. 2022;112(3):600-610.
Wallington D.G., Contessa J.N., Hayman T.J. STING Agonists in Head and Neck Squamous Cell Carcinoma Cancer Journal United States. 2022;28(5):401-406.
Gharzai L.A., Jiang R., Wallington D., Jones G., Birer S., Jairath N., Jaworski E.M., McFarlane M.R., Mahal B.A., Nguyen P.L., Sandler H., Morgan T.M., Reichert Z.R., Alumkal J.J., Mehra R., Kishan A.U., Fizazi K., Halabi S., Schaeffer E.M., Feng F.Y., Elliott D., Dess R.T., Jackson W.C., Schipper M.J., Spratt D.E. Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis Lancet Oncology. 2021;22(3):402-410.
Wallington D.G., Holliday E.B. Preparing Patients for Sexual Dysfunction After Radiation for Anorectal Cancers: A Systematic Review Practical Radiation Oncology. 2021;11(3):193-201.
Dess R.T., Sun Y., Jackson W.C., Jairath N.K., Kishan A.U., Wallington D.G., Mahal B.A., Stish B.J., Zumsteg Z.S., Den R.B., Hall W.A., Gharzai L.A., Jaworski E.M., Reichert Z.R., Morgan T.M., Mehra R., Schaeffer E.M., Sartor O., Nguyen P.L., Lee W.R., Rosenthal S.A., Michalski J.M., Schipper M.J., Dignam J.J., Pisansky T.M., Zietman A.L., Sandler H.M., Efstathiou J.A., Feng F.Y., Shipley W.U., Spratt D.E. Association of Presalvage Radiotherapy PSA Levels after Prostatectomy with Outcomes of Long-Term Antiandrogen Therapy in Men with Prostate Cancer JAMA Oncology. 2020;6(5):735-743.
Jiang C., Wallington D.G., Anker C.J., Lawson D.H., Yushak M.L., Kudchadkar R.R., Tarhini A., Khan M.K. Changing therapeutic landscape for melanoma with multiple brain metastases Neurosurgery. 2020;87(3):498-515.
Taylor A.S., Morgan T.M., Wallington D.G., Chinnaiyan A.M., Spratt D.E., Mehra R. Correlation between cribriform/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22-gene genomic classifier Prostate. 2020;80(2):146-152.
Wallington D.G., Rashid A.S., Buchwald Z.S., Sudmeier L.J., Khan M.K. Complete and Durable Response After Radiation Therapy to Primary Tumor Site of a Patient With Metastatic Anorectal Mucosal Melanoma With Oligoprogression on Nivolumab Advances in Radiation Oncology. 2020;5(3):503-510.
Wallington D., Schauer M., Bauler L.D. Simultaneous presentation of thyroid storm and diabetic ketoacidosis in a previously healthy 21-year-old man BMJ Case Reports. 2019;12